Pioneering Prolonged Release: A Novel Pellet-Based Approach to Anti-Anginal Therapy of Ranolazine

ABSTRACT

Aim: Angina is a clinical syndrome with symptoms attributed to myocardial ischaemia. There are many class of drugs which are used to manage it, among such is ranolazine which acts by inhibiting late Na+ current. Ranolazine is used for the treatment of recurrent angina. So, the aim of the present work was to develop prolonged release pellets incorporated into capsules. Materials and Methods: In the present study, pellets were prepared by the Extruder and Spherodizer equipment using polymer Eudragit L 100, Eudragit S 100, HPMC K15M and red iron oxide using (120, 125, 130 mg) for Eudragit L100, likewise for the other polymers. The concentration of polymers was varied in all the preparations. Results and Conclusion: The effect of polymers was tested to check the prolonged effect by the help of in vitro studies. The FT-IR results indicated that Ranolazine and the other excipients were compatible. The pellets were subjected to different pharmacopoeial tests like tap density, bulk density, rate of flow, angle of repose, microscopic particle, weight variation, drug content and in vitro release studies. The in vitro release studies were carried out using USP type- I dissolution apparatus, i.e. basket type. Which showed that formulation F1 (Drug, Eudragit L100, Mannitol, MCC) showed the best sustained release for a period of 11 hrs. Hence, we conclude the main aim of the envisaged research work is achieved, i.e. sustaining the release of ranolazine without dose dumping.

KEYWORDS

• Ranolazine
• Sustained Release Pellets
• Extrusion and Spheronization
• Pelletization

Showing references and in-text citations exactly as published.

• DOI10.5530/ijper.20261515Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPER.

• Article · VOLUME 60, ISSUE 3Development and Optimization of Memantine-PEGylated PLGA Liposomal Formulation for Nose-to-Brain Delivery in Alzheimer's Disease: A Quality-by-Design (QbD) ApproachAbhish Jadhav, Mrudula Bele · pp. 999–1012Original ArticleSame type: Article
• Article · VOLUME 60, ISSUE 3In vitro Characterisation of an Injectable Composite Graft Material Synthesised from Collagen Extracted from Fish Scales and Eggshell-Derived HydroxyapatiteSruthy Prathap, Rajesh Kashyap Shankar, Nebu George Thomas, Jayachandran Venkatesan, Binsi Puthanpurakkal Kizhakkethil, Suprith Surya, Prathap Mulackal Sreekantantan · pp. 1013–1020Original ArticleSame type: Article
• Article · VOLUME 60, ISSUE 3QbD Approach for Developing Fast-Dissolving Films of Ondansetron Hydrochloride using HPMC E5 and PrimojelKunderu Ravi Shankar, Raghavendra Kumar Gunda, Rayavarapu Sanjay Babu, Pothuri Srinivasa Eswar, Sathvika Avvari, Kollipara Naga Venkata Chenchu Lakshmi, Shaik Aminabee · pp. 1021–1025Original ArticleSame type: Article
• Article · VOLUME 60, ISSUE 3Bile Acid-Based Lipid Nanoparticles to Ameliorate Oral Bioavailability of Gliclazide: A Response Surface Methodology ApproachMuggu Sankara Bhavani, Ravindran Saravanan · pp. 1026–1036Original ArticleSame type: Article